The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency-Reference-Cited by-同舟云学术

The pore size of mesoporous silica nanoparticles regulates their antigen delivery efficiency

Published:2020-06-19 Issue:25 Volume:6 Page:
ISSN:2375-2548
Container-title:Science Advances
language:en
Short-container-title:Sci. Adv.

Author:

Hong Xiaoyu¹^ORCID,Zhong Xiaofang¹,Du Guangsheng¹,Hou Yingying¹,Zhang Yunting¹,Zhang Zhirong¹^ORCID,Gong Tao¹,Zhang Ling²^ORCID,Sun Xun¹^ORCID

Affiliation:

1. Key Laboratory of Drug Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, West China School of Pharmacy, Sichuan University, Chengdu 610041, China.

2. College of Polymer Science and Engineering, Sichuan University, Chengdu 610065, China.

Abstract

The strength of humoral and cellular immune responses is regulated by the properties of mesoporous silica.

Funder

National Natural Science Foundation of China

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference47 articles.

1. Ten years of the Global Alliance for Vaccines and Immunization: challenges and progress

2. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

3. Cross-presentation by dendritic cells

4. The CD8+dendritic cell subset

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current trends in silica based drug delivery systems;European Journal of Medicinal Chemistry Reports;2024-12

2. Gemcitabine Resistant Triple Negative Breast Tumor Derived Mesoporous Silicon Nanovaccine Overcame Drug Resistance;Advanced Functional Materials;2024-09-13

3. A Magnetically Driven Biodegradable Microsphere with Mass Production Capability for Subunit Vaccine Delivery and Enhanced Immunotherapy;ACS Applied Materials & Interfaces;2024-09-12

4. ROS-responsive charge reversal mesoporous silica nanoparticles as promising drug delivery system for neovascular retinal diseases;Journal of Controlled Release;2024-09

5. Glucosylated Nanovaccines for Dendritic Cell-Targeted Antigen Delivery and Amplified Cancer Immunotherapy;ACS Nano;2024-08-28